Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Equity Ratio (2020 - 2025)

Caribou Biosciences has reported Equity Ratio over the past 6 years, most recently at 0.7 for Q4 2025.

  • Quarterly Equity Ratio fell 13.71% to 0.7 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.7 through Dec 2025, down 13.71% year-over-year, with the annual reading at 0.7 for FY2025, 13.71% down from the prior year.
  • Equity Ratio was 0.7 for Q4 2025 at Caribou Biosciences, down from 0.73 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.88 in Q4 2021 and troughed at 0.3 in Q2 2021.
  • The 5-year median for Equity Ratio is 0.81 (2022), against an average of 0.75.
  • Year-over-year, Equity Ratio soared 374.21% in 2022 and then decreased 13.71% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.88 in 2021, then dropped by 8.18% to 0.8 in 2022, then grew by 5.89% to 0.85 in 2023, then fell by 5.28% to 0.81 in 2024, then decreased by 13.71% to 0.7 in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Equity Ratio are 0.7 (Q4 2025), 0.73 (Q3 2025), and 0.75 (Q2 2025).